FYARRO 5 mg/mL
Sirolimus · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · Aadi Bioscience, Inc.
No Recall History
Plain English
FYARRO is a injection, powder, lyophilized, for suspension containing sirolimus at 5 mg/mL, taken intravenous. Manufactured by Aadi Bioscience, Inc..
Key Facts
- Brand Name
- FYARRO
- Generic Name
- Sirolimus
- NDC Code (Product)
80803-153- Manufacturer
- Aadi Bioscience, Inc.
- Strength
- 5 mg/mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA213312
- Drug Class
- mTOR Inhibitor Immunosuppressant [EPC]; Kinase Inhibitor [EPC]
- Marketing Start
- 12/06/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is FYARRO used for?
FYARRO contains Sirolimus. It is a injection, powder, lyophilized, for suspension taken intravenous. Consult your doctor for specific uses.
Is FYARRO a controlled substance?
FYARRO is not classified as a controlled substance by the DEA.
What is the generic name for FYARRO?
The generic name for FYARRO is Sirolimus. There are 11 other brand versions of Sirolimus.
What is the NDC code for FYARRO 5 mg/mL?
The NDC (National Drug Code) for FYARRO 5 mg/mL is 80803-153, listed by Aadi Bioscience, Inc..